(HealthDay)—For patients with type 2 diabetes, direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) is associated with improved glycemic control and reduced antidiabetic medication use, according to a study ...
1
0
The School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) recently conducted a clinical study on Chinese medicine treatment of chronic renal failure. The findings indicated that the effective stability rate ...
1
0
A new study published by JAMA Psychiatry examines the comparative effectiveness of antipsychotic treatments for the prevention of psychiatric rehospitalization and treatment failure among a nationwide group of patients with ...
0
0
In a world-first discovery, scientists at Sydney's Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.
111
0
In an effort to find new strategies to personalize treatment for pediatric patients, Seattle Children's has opened the first clinical trial applying next-generation T-cell receptor (TCR) sequencing and single-cell gene expression ...
2
0
Approximately one in four (22.1 percent) adults prescribed an antibiotic in an outpatient setting (such as a doctor's office) for community-acquired pneumonia does not respond to treatment, according to a new study presented ...
2
0
A team of scientists from The University of Western Australia has developed a screening test that quickly confirms antibiotic efficacy. Their method is able to ensure the most effective antibiotics are prescribed sooner.
1
0
Children with bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA), a common antibiotic-resistant bacteria, are less likely to die than adults with this condition and have different risk factors ...
0
0
Scientists at Indiana University have identified a therapy that could help reverse damage from acute kidney injury and eliminate the need for dialysis treatment in the future.
0
0
Researchers have completed a randomized clinical trial in patients with heart failure with preserved ejection fraction (HFpEF), which currently has no effective treatment for reducing morbidity and mortality.
0
0
Subscribe to rss feed
